Stay updated with breaking news from Registration Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces...
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and
Clichy, France – April 23, 2024 FIRST QUARTER 2024 RESULTS1 Flat net sales at constant currency excl. Argentina. Full-year outlook...
23 April 2024 /// www.id-logistics.com /// PRESS RELEASE 2023 Universal Registration Document made available ...
Half-year FY24 Results April 23 rd, 2024 Forward looking statement ...